Essential Pharma Announces the Acquisition of HALDOL®
07. Dezember 2022 02:00 ET
|
Essential Pharma
Essential Pharma Announces the Acquisition of HALDOL® HALDOL® is a first-generation ‘typical’ antipsychotic for the treatment of schizophrenia and some other psychiatric conditions The acquisition...